In addition to our premium weight loss medications, we also offer compounded GLP-1 microdosing options
Choose Ozempic/Wegovy if You want the most studied, longest-track-record option You prefer the NHS or a standard private clinic route 15% weight loss meets your goal You're needle-averse and want the most established self-injector pen Choose Mounjaro if You want the best results available on prescription right now You prefer full medical oversight You don't want to self-manage reconstitution ~2127% weight loss is your target Choose Retatrutide if You want the highest ceiling available though 28.3% is the 12mg figure, and 46mg is where most people land You're comfortable self-managing the research peptide process Cost is a factor the research route is far cheaper You've already tried Mounjaro or Ozempic and want to step up You're willing to start low and titrate slowly through the initial side effects "Comfortable self-managing" is the line doing the most work in that list

0% Weight Loss per STEP Trials STEP trial studied FDA-approved Wegovy (semaglutide 2.4mg), not compounded semaglutide
Shiri Levy, a board-certified physician who specializes in managing disorders of the thyroid, parathyroid, pituitary and adrenal glands, lipids, osteoporosis and diabetes
Quality Standards at PeptideLabUK PeptideLabUK maintains professional laboratory standards: Sterile Packaging Each vial is sealed and labelled clearly for research use
Fuel your body with the Total Rho Stack by Rho Nutrition